Vitreoretinopathy affects the vitreous gel and the retina, which can blur vision and cause floaters or flashes. People with vitreoretinopathy may notice vision distortion, blind spots, or trouble seeing at night, and doctors may see scarring or retinal pulling. It can be short term after an eye injury or surgery, or long term in inherited forms like familial exudative vitreoretinopathy. Most people with vitreoretinopathy are diagnosed in childhood or adulthood, and severity varies, but serious cases can threaten sight if not treated. Treatment often includes eye injections, laser, or surgery, and urgent care is needed if there is a retinal detachment.

Overview

Vitreoretinopathy

Symptoms

Vitreoretinopathy can cause new floaters, flashes of light, blurred or distorted vision, and trouble seeing at night or to the sides. Some notice a dark curtain or sudden drop in vision from retinal detachment. Early symptoms of vitreoretinopathy are painless.

Outlook and prognosis

Many living with vitreoretinopathy do well with timely eye care, but vision can fluctuate and sometimes decline, especially if retinal detachments recur. Regular specialist follow-up and prompt treatment help preserve sight. Genetic forms may progress over time and affect both eyes.

Causes and risk factors

Vitreoretinopathy often develops after retinal detachment, eye surgery, or blunt eye trauma, and with intraocular inflammation. Biological risks include severe nearsightedness and older age; genetic forms run in families. Activities that raise eye-injury risk (e.g., contact sports) increase risk.

Genetic influences

Genetics plays a major role in vitreoretinopathy, especially in inherited forms where single-gene variants can drive tissue scarring and retinal detachment. Family history increases risk. Genetic testing and counseling can guide monitoring, prognosis, and family planning.

Diagnosis

Diagnosis of vitreoretinopathy relies on a dilated eye exam and retinal imaging (OCT, fluorescein angiography, ultrasound). Doctors also review symptoms and history, including prior retinal surgery or trauma. Genetic tests may be considered when inherited forms are suspected.

Treatment and drugs

Treatment for vitreoretinopathy focuses on protecting sight and stabilizing the retina. Depending on the type and severity, options may include anti‑VEGF or steroid eye injections, laser or cryotherapy, and retinal surgery (such as vitrectomy, membrane peel, or buckle). Regular follow‑up guides timing and combination of treatments.

Symptoms

Changes in vision can creep in—new floaters, wavy lines, or a smudge that won’t clear—even when the eye doesn’t feel sore. You might notice small changes at first, and early symptoms of vitreoretinopathy often include sudden floaters or light flashes that seem to come from nowhere. What you notice can differ widely and may shift over weeks to months. Seek urgent eye care if a dark curtain appears or vision drops suddenly.

New floaters

You may see spots, strands, or cobweb-like shapes that drift. They move with eye movement and are most noticeable on bright backgrounds. These can be an early sign in vitreoretinopathy.

Light flashes

You may notice brief streaks or flickers in side vision, especially in the dark. They may signal the retina is being tugged. In vitreoretinopathy, this can happen when scar tissue pulls on the retina.

Blurry or hazy vision

Vision may look smeared, like a fingerprint on glasses. It can come and go or stay. Many people with vitreoretinopathy notice blurring that doesn’t clear with blinking.

Wavy or bent lines

Straight lines look bent, wavy, or broken. In medical terms, this is metamorphopsia; in everyday life, it shows up as doorframes or text lines that seem rippled. This distortion can affect reading and judging distances.

How people usually first notice Vitreoretinopathy?

Many people first notice vitreoretinopathy when their vision starts to change—new floaters that look like tiny spots or threads, flashes of light, or a curtain-like shadow creeping over part of the view. Some develop blurred or distorted vision that makes reading or recognizing faces harder, and these changes can come on suddenly if the retina pulls away (retinal detachment) or more gradually with scar tissue. Because the first signs of vitreoretinopathy can mimic common, less serious issues, any sudden increase in floaters, flashes, or a shadow in one eye is a reason to seek urgent eye care.

Dr. Wallerstorfer Dr. Wallerstorfer

Types of Vitreoretinopathy

Vitreoretinopathy includes several clinical variants that affect the gel (vitreous) and the light‑sensing layer (retina) at the back of the eye. These variants can be inherited or acquired, and they differ in when they start, how fast they progress, and which vision problems show up first. Daily life often makes the differences between symptom types clearer. Knowing the main types of vitreoretinopathy can help you and your eye specialist talk through the early symptoms of vitreoretinopathy and plan follow-up.

Proliferative variant

New, fragile blood vessels grow on the retina and into the vitreous. This can lead to bleeding, floaters, and scarring that tugs the retina out of place. Vision may blur or dim, especially if the macula is involved.

Tractional variant

Scar tissue forms on the retinal surface and contracts like a tightening film. This pulling can cause a tractional retinal detachment with wavy or shadowed vision. Peripheral vision often declines before central vision is affected.

Exudative variant

Fluid leaks under the retina without a tear. People may notice distorted straight lines or a dark patch in part of their view. Swelling can come and go but may worsen over time if untreated.

Inherited FEVR

Familial exudative vitreoretinopathy (FEVR) starts in childhood or early adulthood. Peripheral retinal blood vessels are underdeveloped, leading to leakage, scarring, and traction. Severity ranges from few symptoms to significant vision loss in one or both eyes.

Stickler syndrome

This genetic collagen disorder often includes vitreoretinopathy with an early, liquefied vitreous. People face a high risk of retinal tears and detachments, sometimes in youth. Nearsightedness and hearing or joint features may also be present.

Wagner syndrome

A rare inherited vitreoretinopathy with progressive vitreous changes and chorioretinal atrophy. Night vision and peripheral vision can fade gradually. Cataracts and retinal detachment risk may increase over time.

Retinopathy of prematurity

In premature infants, abnormal vessel growth and scarring can cause a tractional vitreoretinopathy. Some children stabilize, while others develop detachments that threaten vision. Early screening and treatment are key to outcomes.

Post‑surgical PVR

Proliferative vitreoretinopathy (PVR) can develop after retinal detachment repair or major eye injury. Sheets of scar tissue form and contract, redetaching the retina. Symptoms may recur with new floaters, distortion, or a curtain‑like shadow.

What genetics can tell you about symptoms

Some inherited changes in collagen genes like COL2A1 and COL11A1 can make the gel in the eye more fragile, leading to floaters, flashes, and early retinal tears or detachment. Variants in FZD4, LRP5, or TSPAN12 can narrow retinal vessels, causing poor night vision, peripheral vision loss, and repeated detachments.

Dr. Wallerstorfer Dr. Wallerstorfer

Causes and risk factors

Most cases of vitreoretinopathy develop after problems with the retina, such as a detachment, eye surgery, or a hard blow to the eye. Inflammation inside the eye, bleeding into the gel, and repeated operations can raise the chance of scar tissue that pulls on the retina. Rare forms of vitreoretinopathy are genetic, where a gene change affects how the retina and its blood vessels develop from birth. Some risks are modifiable (things you can change), others are non-modifiable (things you can’t). Risk factors for vitreoretinopathy include smoking, severe eye injury, long-standing retinal tears, and a family history of inherited vitreoretinopathy.

Environmental and biological risk factors

Vitreoretinopathy affects the gel and light-sensing layer in the back of the eye, often through scarring that tugs on the retina. Knowing what raises risk can help you act before early symptoms of vitreoretinopathy appear. Doctors often group risks into internal (biological) and external (environmental). Below are common factors that can set the stage.

Retinal detachment

When the retina pulls away, cells can migrate and form membranes on its surface. This scarring response raises the chance of vitreoretinopathy. Larger or longer detachments pose more risk.

Large retinal tears

Bigger or multiple tears release more cells into the eye. These cells can drive scarring and contraction. This makes problems more likely after repair.

Eye trauma

Blunt or penetrating injury triggers inflammation and bleeding. That environment promotes scar tissue that can lead to vitreoretinopathy. More severe injuries carry higher risk.

Retinal surgery

Operations to fix detachments or tears activate healing processes. Some healing cells form membranes that contract. Multiple surgeries increase the likelihood.

Genetic risk factors

For many, Vitreoretinopathy starts with inherited changes that shape how the retina and the gel-like vitreous grow and connect. Some risk factors are inherited through our genes. Different gene changes can run in families in dominant, recessive, or X-linked patterns, and the impact can vary even between two eyes of the same person. Genetic counseling or testing can clarify the genetic causes of vitreoretinopathy and help families understand patterns of risk.

Gene illustration
  • FEVR genes: Changes in genes that guide retinal blood vessel growth, such as FZD4, LRP5, TSPAN12, or NDP, can cause a form of vitreoretinopathy called familial exudative vitreoretinopathy (FEVR). This can leave the outer retina without enough vessels, leading to leakage, scarring, and traction that raise detachment risk. People with the same risk factor can have very different experiences.

  • Stickler syndrome: Variants in collagen genes (for example COL2A1 or COL11A1) change the structure of the vitreous and support tissues. Many living with this condition have early-onset floaters and a higher lifetime chance of retinal tears or detachment. It most often follows a dominant pattern, so each child has a 1 in 2 chance to inherit the change.

  • Wagner syndrome: Changes in the VCAN gene alter the gel matrix of the vitreous, thinning it and loosening its attachment to the retina. This inherited eye condition can cause night-vision difficulties, peripheral retinal changes, and gradual vision decline. It is usually dominant, with severity varying within a family.

  • Norrie disease: Variants in the NDP gene disrupt early retinal vessel development, often causing severe eye disease involving the retina and vitreous from infancy. Because it is X-linked, males are typically affected while females may be carriers with mild or no eye findings. Some families also report hearing changes over time.

  • KIF11 variants: Changes in KIF11 can produce FEVR-like vitreoretinopathy with areas of retina lacking blood vessels. Eye findings can occur alone or with other features in some families. Inheritance is most often dominant, but expression can vary widely.

  • RS1 retinoschisis: Variants in the RS1 gene can cause splitting of the central retina with fragile blood vessels and vitreoretinal traction. This X-linked condition mainly affects males and can range from mild blurring to recurrent bleeding. Detachment risk increases when traction builds.

  • PVR risk variants: Common differences in genes that regulate inflammation and scar formation, including p53 and TNF pathways, may slightly raise the chance of proliferative vitreoretinopathy after a retinal detachment or surgery. These variants do not guarantee PVR and their effects appear modest. Science continues to uncover how these elements interact.

Dr. Wallerstorfer Dr. Wallerstorfer

Lifestyle risk factors

Several day-to-day habits can influence how vitreoretinal problems start, worsen, or respond to treatment. Here are lifestyle risk factors for Vitreoretinopathy that affect retinal blood flow, inflammation, and healing. Tailoring routines around vision care can help reduce traction, scarring, and exudation risks.

Smoking

Tobacco toxins damage retinal microvessels and increase intraocular inflammation that can drive vitreoretinal scarring. Quitting lowers postoperative proliferative vitreoretinopathy risk and improves surgical outcomes.

Poor glycemic control

Frequent high blood sugars fuel retinal ischemia and abnormal vessel growth that can lead to tractional vitreoretinopathy in people with diabetes. Keeping A1c in target reduces progression and post-procedure complications.

High blood pressure

Chronic hypertension raises shear stress on retinal vessels and promotes leakage that worsens exudative changes. Managing sodium, alcohol, and weight helps stabilize pressures and protect the vitreoretina.

Unbalanced diet

Diets low in omega-3s, lutein/zeaxanthin, and antioxidants may weaken retinal resilience and slow healing. Eating fish, leafy greens, and colorful produce may support retinal function and recovery after retinal procedures.

Risk prevention

Vitreoretinopathy includes several problems that affect the gel inside the eye and the retina, sometimes after an injury or eye surgery, and sometimes due to inherited changes. You can’t control every cause, but you can lower risks and catch issues early so vision can be protected. Prevention works best when combined with regular check-ups. Regular eye care and quick action for new symptoms make the biggest difference.

Protective eyewear

Use shatter‑resistant goggles for sports, yard work, and jobs with flying debris. Preventing eye injuries lowers the chance of retinal tears that can lead to vitreoretinopathy.

Know warning signs

New flashes, a sudden shower of floaters, or a curtain over part of vision need same‑day eye care. Acting fast on early symptoms of vitreoretinopathy can prevent worsening damage.

Post‑surgery care

After retinal procedures, use prescribed drops, avoid heavy lifting, and keep follow‑up visits. Careful healing helps lower the risk of proliferative vitreoretinopathy forming.

Prompt trauma care

If the eye is hit or cut, seek urgent evaluation even if pain is mild. Quick treatment of retinal tears or bleeding can reduce later scarring on the retina.

Transmission

Vitreoretinopathy isn’t contagious—you can’t catch it or pass it on through casual contact, coughing, sex, or blood exposure. Some forms, especially familial exudative vitreoretinopathy, can be inherited; this is how vitreoretinopathy is inherited in many families, most often in an autosomal dominant pattern (one altered gene copy from either parent), and less often autosomal recessive (both gene copies carry the change). A child may also be the first in the family if a new genetic change arises. Because risk involves parent‑to‑child genetic transmission only, infection-control steps don’t apply, but relatives may consider genetic counseling.

Gene illustration

When to test your genes

Vitreoretinopathy includes several inherited and acquired forms, so genetic testing is most useful if there’s a family history of early retinal detachment, unexplained vision loss, or known pathogenic variants. Test if you have compatible eye findings or affected relatives, especially before surgery or pregnancy. Results can guide surveillance, treatment timing, and relatives’ screening.

Dr. Wallerstorfer Dr. Wallerstorfer

Diagnosis

Changes in vision—like new floaters, wavy lines, or trouble seeing in dim light—often prompt the first visit, especially if there’s a family history or symptoms starting in childhood. Doctors usually begin with a thorough eye exam and retinal imaging to see the back of the eye in detail. From there, the diagnosis of vitreoretinopathy is based on recognizable patterns, whether it appears to be inherited or not, and may be confirmed with genetic testing when appropriate.

Dilated eye exam

The specialist looks closely at the vitreous gel and retina for telltale features such as abnormal blood vessels, folds, or areas of thinning. These clinical features help separate vitreoretinopathy from more common causes of vision changes.

Retinal OCT imaging

Optical coherence tomography (OCT) creates cross‑sectional pictures of the retina. It shows thinning, scarring, or traction that support a vitreoretinopathy pattern.

Widefield photography

Panoramic retinal photos document how far changes extend across the back of the eye. This helps track progression and compare findings between eyes and over time.

Fluorescein angiography

A small dye injection highlights blood flow in retinal vessels. Leaky, missing, or tangled vessels on this test can point toward inherited vitreoretinopathy and help rule out other vascular diseases.

Stages of Vitreoretinopathy

Vitreoretinopathy does not have defined progression stages. This is because it’s an umbrella term for several conditions that affect the clear gel and the light‑sensing layer of the eye, and each subtype is tracked differently. Different tests may be suggested to help sort out the cause and map out any changes over time. Doctors usually look at early symptoms of vitreoretinopathy—like new floaters, flashes, or blurred vision—and confirm findings with a dilated eye exam and imaging (such as OCT or fluorescein pictures), then monitor according to the specific subtype involved.

Outlook and prognosis

Looking at the long-term picture can be helpful. For many people with vitreoretinopathy, the outlook depends on how early it’s found, where the retina is affected, and how well treatments like laser, injections, or surgery control scarring and fluid. Vision can stay stable for years if the retina remains attached and swelling is managed. When the retina pulls away or scar tissue contracts, vision often drops, sometimes quickly. Early care can make a real difference, especially if you notice early symptoms of vitreoretinopathy such as flashes, new floaters, a shadow at the edge of vision, or blurry central sight.

The outlook is not the same for everyone, but most people with vitreoretinopathy do not face life‑threatening risks; the condition mainly affects sight, not lifespan. Severe scarring (proliferative vitreoretinopathy) raises the chance of repeat detachments and can make surgery harder, yet modern techniques still help many maintain functional vision for reading, driving, and work. Some people experience periods of relative stability, while others notice stepwise changes after procedures or flare‑ups. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle, including whether there’s an inherited retinal disorder, diabetes, prior eye surgery, smoking, or eye trauma.

Knowing what to expect can ease some of the worry. If one eye is affected, protecting the other eye and using low‑vision tools can keep daily life moving—adjusting lighting, using magnifiers, and planning follow‑ups. With ongoing care, many people maintain independence and adapt routines even if vision declines. Talk with your doctor about what your personal outlook might look like, including your risk of recurrence, the role of genetic testing if an inherited form is suspected, and how to spot warning signs early.

Long-term effects

Vitreoretinopathy can change how clearly and comfortably you see over time, sometimes in ways that affect reading, driving, or recognizing faces. Some people notice dips in sharpness, wavy or missing spots in vision, or trouble with low light that slowly becomes more noticeable. Long-term effects vary widely, and your experience may not match someone else’s with vitreoretinopathy. People sometimes only recognize the early symptoms of vitreoretinopathy in hindsight, because they can be subtle at first.

Central vision blur

Fine detail may fade or look smudged, making print or faces harder to make out. This reduced clarity in vitreoretinopathy may come and go before becoming steadier.

Peripheral field loss

Side vision can narrow, which may make crowds, stairs, or crossing streets feel less certain. Some notice bumping into objects on one side.

Distortion and warping

Straight lines may look bent or wavy, and shapes can seem stretched. This can affect reading lines of text or judging distances.

Night and low-light trouble

Dim settings can feel murky, with glare from headlights or halos around lights. Contrast may drop, making it harder to see steps or curbs.

How is it to live with Vitreoretinopathy?

Living with vitreoretinopathy often means adapting to vision that can change over time—blurring, distorted lines, or new floaters can interrupt reading, driving, and tasks that rely on fine detail. Many find they plan their days around good lighting, larger-print tools, and scheduled eye checks, while staying alert to sudden symptoms that need urgent care. Family, friends, and coworkers may help with transportation and visual tasks, and small adjustments—like high-contrast labels at home or shared calendars—can ease strain for everyone. With consistent follow-up, low-vision supports, and clear communication, people can keep routines and independence while protecting the vision they have.

Treatment and drugs

Treatment for vitreoretinopathy focuses on protecting vision, repairing retinal damage, and preventing further scarring or detachment. Depending on the type and severity, doctors may recommend procedures such as laser therapy to seal weak areas, injections into the eye to calm inflammation or reduce abnormal blood vessel growth, or surgery (like vitrectomy with membrane peeling) to remove scar tissue and reattach the retina. Not every treatment works the same way for every person, so your plan is tailored to your eye findings, vision needs, and any underlying cause such as diabetes or prior trauma. Alongside medical treatment, lifestyle choices play a role, including managing blood sugar, blood pressure, and avoiding smoking to support retinal health. Ask your doctor about the best starting point for you, and what to watch for as early symptoms of vitreoretinopathy can change quickly.

Non-drug treatment

Vitreoretinopathy can affect day-to-day vision—reading street names, recognizing faces across a room, or driving at dusk may become harder. Alongside medicines, non-drug therapies can stabilize the retina, reduce the risk of detachments, and help you make the most of your sight. Understanding early symptoms of vitreoretinopathy helps you and your eye team decide when to act and which approach fits best. Options range from in-office laser or freezing treatments to surgery and practical vision support.

Regular monitoring

Scheduled dilated eye exams and retinal imaging can catch small changes before they threaten vision. Your eye doctor may adjust how often you’re seen based on how active your vitreoretinopathy is.

Laser therapy

Focused laser spots can seal weak areas or small retinal tears to lower the chance of detachment. This is often done in the clinic with numbing drops and brief light exposure.

Cryotherapy

A gentle freezing probe placed on the outer eye can seal a tear when laser isn’t feasible. It creates a controlled scar to secure the retina.

Scleral buckle

A soft band placed around the eye helps push the wall of the eye against the retina. This surgical support can reduce traction linked to vitreoretinopathy and aid reattachment.

Your genes may have an impact on how drugs work for you

Think of treatment like adjusting a dimmer switch: genes can set how your eye tissues respond to medicines for vitreoretinopathy and how quickly your body handles those drugs. Variants in collagen or signaling genes may affect drug effectiveness or side‑effects, guiding personalized dosing.

Dr. Wallerstorfer Dr. Wallerstorfer

Pharmacological treatments

Vitreoretinopathy is usually managed with eye surgery; medicines are used to calm inflammation, reduce swelling, and lower the risk of scarring that can tug the retina again. Most drug treatments are supportive or off-label and are timed around surgery rather than replacing it. Not everyone responds to the same medication in the same way. Your eye specialist will tailor choices to the type of vitreoretinopathy and any related issues like diabetic eye disease.

Steroid drops/injections

Prednisolone acetate drops, dexamethasone drops, or triamcinolone acetonide injections help quiet inflammation before and after surgery. This can lower swelling and reduce the chance of scarring that leads to retinal pull; catching early symptoms of vitreoretinopathy and treating inflammation promptly may support healing. Side effects may include higher eye pressure and, over time, cataract changes.

Dexamethasone implant

A tiny steroid implant (dexamethasone) placed inside the eye can steadily reduce inflammation and macular swelling. It’s often used around surgery or when drops aren’t enough. Monitoring for eye pressure rises is important.

NSAID eye drops

Ketorolac, nepafenac, or bromfenac can ease inflammation and discomfort. They support recovery but are less potent than steroids for preventing scarring. Stinging on instillation can occur but often settles.

Intravitreal methotrexate

Low‑dose methotrexate injections given into the eye (often as a short series) are used off‑label to limit the cell growth and scarring seen in proliferative vitreoretinopathy. This approach may help reduce recurrence after surgery. Possible side effects include surface eye irritation that is usually watched closely.

Genetic influences

Many families notice similar eye problems across generations, and for many, vitreoretinopathy has a genetic basis that affects how the clear gel in the eye and the retina form and stay healthy. Family history is one of the strongest clues to a genetic influence. In some families, a single gene change passed from one parent can be enough; in others, a child needs a gene change from both parents, and a few types are linked to the X chromosome and tend to affect males more often. Even within one family, the age it starts and early symptoms of vitreoretinopathy can vary—one person may notice new floaters or mild blurring, while a relative develops more significant vision changes. It can also appear for the first time in a child because of a new gene change, so the absence of family history doesn’t rule it out. Genetic counseling and testing can help confirm the cause, estimate risks for relatives, and guide follow‑up and care.

Is Vitreoretinopathy genetic?

Genetics plays a major role in vitreoretinopathy, especially in inherited forms where single-gene variants can drive tissue scarring and retinal detachment. Family history increases risk. Genetic testing and counseling can guide monitoring, prognosis, and family planning.


Pharmacogenetics—how genetics influence drug effects

For people living with vitreoretinopathy, inherited changes that affect how retinal blood vessels develop can shape how the condition behaves and how well certain treatments, such as laser, surgery, or anti-VEGF eye injections, may help. Genetic testing for vitreoretinopathy can pinpoint the subtype, guide how closely to monitor each eye, and sometimes influence decisions about timing of laser or the cautious use of anti-VEGF medicines in infants and children. Pharmacogenetics is still emerging here; there isn’t a routine, approved gene test that tells doctors which drug or dose will work best for vitreoretinopathy today. Not every difference in response is genetic, but your results—together with age, eye findings, and prior treatment response—can help your retina specialist choose between surgery, laser, and medication and tailor follow-up. If steroids are part of care, your team will check eye pressure regularly, since some people are sensitive to steroid-related pressure rises; this is based on clinical monitoring rather than pharmacogenetic testing. As research grows, doctors may learn how specific gene patterns relate to anti-VEGF benefit or risk, bringing more precise drug treatment for vitreoretinopathy in the future.

There are 0 Drugs to treat Vitreoretinopathy
Currently no available information

Interactions with other conditions

When vitreoretinopathy occurs alongside other eye or whole‑body conditions, the combined effects can be greater than either on its own. It often intersects with diabetes‑related eye disease, high myopia (severe nearsightedness), and past or ongoing eye inflammation, which can all increase the chance of scar tissue forming on the retina or make it harder to control. A condition may “exacerbate” (make worse) symptoms of another, so early symptoms of vitreoretinopathy—like new floaters, flashes, or a shadow in the side vision—can be easier to miss when diabetic changes or inflammation are also active. Some inherited connective tissue disorders, including Marfan syndrome or Stickler syndrome, can involve the vitreous and retina as part of a broader pattern, so family history can be a helpful clue. Blood disorders that affect the retina’s circulation, such as sickle cell disease, and conditions like retinopathy of prematurity may also overlap with vitreoretinopathy and influence how quickly problems progress. These interactions vary widely, and coordinated care between your eye specialist and other clinicians usually leads to better timing of treatments and closer monitoring tailored to your overall health.

How genes can cause diseases

Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.

Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.

History

Throughout history, people have described sudden changes in sight—floater-like shadows, a haze that wouldn’t clear, or a curtain drifting across part of the view. In family letters and clinic notes alike, these stories hinted at problems not just in the clear gel of the eye but also where that gel meets the light-sensing layer. Today, those linked problems are grouped under vitreoretinopathy, a word that reflects both the vitreous (the eye’s gel) and the retina working as a connected unit.

From early theories to modern research, the story of vitreoretinopathy shows how observation led to careful mapping of what goes wrong. In the 19th and early 20th centuries, doctors peered with simple lenses and drew what they saw: tugging on the retina, tiny scars, and later, detachment. Surgery was limited, so most knowledge came from watching what unfolded over time. As better lights and lenses arrived, clinicians realized the vitreous could pull like a sticky band on the retina, setting off tears and scar tissue that curled the retina back down.

Mid-century, new techniques—indirect ophthalmoscopy, then ultrasound—made it possible to see changes before a full detachment. The condition once considered rare, now recognized as a spectrum, included traction from bleeding, inflammation after injury, and scarring after earlier surgery. “Proliferative” forms, where scar tissue grows and contracts on the retinal surface, were named and tracked, helping surgeons plan timing and approach.

By the late 20th century, microsurgery transformed outcomes. Vitrectomy, which removes the gel, let surgeons relieve pulling forces and carefully flatten the retina. With each decade, classification systems matured, separating features seen on exam (like membranes or folds) from symptoms people reported (like distortion or missing patches of sight). This shared language improved clinical trials and sped up practical advances, including better surgical tools, tamponade agents like gas or silicone oil, and ways to limit scarring after repair.

Genetics then added another layer. Families and communities once noticed patterns—relatives who developed retinal problems earlier in life or after minor trauma. Advances in genetics linked certain inherited vitreoretinopathies to changes in genes that guide how the vitreous forms or how the retina anchors, explaining why some eyes are more prone to traction and detachment. This work also showed why the condition varies so widely, from mild floaters to severe scarring.

In recent decades, awareness has grown that vitreoretinopathy is not one disease but a set of related pathways that end with similar damage: pulling, tearing, and scarring where the gel and retina meet. Imaging such as optical coherence tomography now reveals microscopic layers and early warning signs, making it easier to intervene before vision is lost. The history of vitreoretinopathy is ultimately a steady move from rough sketches at the slit lamp to precise, targeted care, with a clear thread: the earlier we recognize traction and scarring, the better we can protect sight.

DISCLAIMER: The materials present on Genopedia.com, such as text, images, graphics, among other items (“Content”), are shared purely for informational reasons. This content should not replace professional health advice, medical diagnoses, or treatment procedures. Whenever you have health concerns or questions, it’s always recommended to engage with your doctor or another appropriate healthcare provider. If you read something on the Genopedia.com site, do not neglect professional medical counsel or delay in obtaining it. In case you believe you’re dealing with a medical crisis, get in touch with your medical professional or call emergency without delay. Genopedia.com doesn’t advocate for any particular medical tests, healthcare providers, products, methods, beliefs, or other data that could be discussed on the site. Please also note that the content, originally written in English and in part created with the help of artificial intelligence, is provided without any warranty, and any reliance on information offered by Genopedia.com, its staff, contributors invited by Genopedia.com, or site users is entirely at your own risk.
Genopedia © 2026 all rights reserved